{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:31:51Z","timestamp":1772825511526,"version":"3.50.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016150","name":"Fondation OCP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Animal venom, known for its complex biochemical composition, presents a valuable source of therapeutic molecules, particularly for antiviral applications. Despite this potential, the industrial use of venom remains limited, with fewer than a dozen venom-derived compounds reaching commercial markets. This study underscores the significance of exploring venom\u2019s natural diversity as a reservoir for novel bioactive compounds that could drive innovative drug development. We investigated the venom of the Moroccan black scorpion\n                    <jats:italic>Androctonus mauritanicus (Am)<\/jats:italic>\n                    , applying solid-phase extraction (SPE) and high-performance reversed-phase liquid chromatography (RP-HPLC) to fractionate the venom into 80 distinct samples. These fractions were subjected to detailed analysis using advanced mass spectrometry techniques, including ESI-MS, Q-TOF LC\/MS, and Q-Exactive LC\/MS. In total, 507 unique molecular masses were identified, with several fractions enriched in neurotoxins targeting ion channels (NaScTxs, KScTxs, CaScTxs, and ClScTxs), highlighting their therapeutic relevance. Fractions containing inhibitory molecules targeting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike S protein were identified through\n                    <jats:italic>in vitro<\/jats:italic>\n                    validation via competitive ELISA, showing multiple levels of inhibitory potential. These findings demonstrate the antiviral activity of venom-derived molecules and reveal promising opportunities for venom-based industrial applications targeting SARS-CoV-2. In conclusion, this study not only emphasises the antiviral properties of specific venom molecules but also opens pathways for industrial drug development, offering potential tools to combat emerging viral diseases.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2025.1678606","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:24:51Z","timestamp":1762151091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of Androctonus mauritanicus venom and in vitro screening of SARS-CoV-2 entry inhibitors candidates"],"prefix":"10.3389","volume":"16","author":[{"given":"Reda","family":"Chahir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Galan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Hboub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Salim","family":"Lahlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Chakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinde","family":"Aassila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reda","family":"Ben Mrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najat","family":"Bouchmaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto","family":"St\u00f6cklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachid","family":"El Fatimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoual","family":"Oukkache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.pain.2013.03.037","article-title":"The scorpion toxin Amm VIII induces pain hypersensitivity through gain-of-function of TTX-sensitive Na+ channels","volume":"154","author":"Abbas","year":"2013","journal-title":"Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/0253-7613.190742","article-title":"Scorpion (A. bicolor) venom exhibits cytotoxicity and induces cell cycle arrest and apoptosis in breast and colorectal cancer cell lines","volume":"48","author":"Al-Asmari","year":"2016","journal-title":"Indian J. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.peptides.2013.10.021","article-title":"Scorpion venom peptides with no disulfide bridges: a review","volume":"51","author":"Almaaytah","year":"2014","journal-title":"Peptides"},{"key":"B5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.peptides.2012.03.016","article-title":"Antimicrobial\/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog","volume":"35","author":"Almaaytah","year":"2012","journal-title":"Peptides"},{"key":"B6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10989-013-9350-3","article-title":"Mauriporin, a novel cationic \u03b1-Helical peptide with selective cytotoxic activity against prostate cancer cell lines from the venom of the scorpion Androctonus mauritanicus","volume":"19","author":"Almaaytah","year":"2013","journal-title":"Int. J. Pept. Res. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbapap.2005.08.010","article-title":"Proteomic analysis of the venom and characterization of toxins specific for Na+-and K+-channels from the Colombian scorpion Tityus pachyurus","volume":"1764","author":"Barona","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbrc.2019.10.115","article-title":"AaHIV a sodium channel scorpion toxin inhibits the proliferation of DU145 prostate cancer cells","volume":"521","author":"BenAissa","year":"2020","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/pmic.200700948","article-title":"Proteomic analysis of the venom of Heterometrus longimanus (Asian black scorpion)","volume":"8","author":"Bringans","year":"2008","journal-title":"Proteomics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.toxicon.2011.12.013","article-title":"Turkish scorpion B. macrocentrus: general characterization of the venom and description of Bu1, a potent mammalian Na+-channel \u03b1-toxin","volume":"59","author":"Caliskan","year":"2012","journal-title":"Toxicon"},{"key":"B11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/BCJ20160577","article-title":"Venomics: integrative venom proteomics and beyond","volume":"474","author":"Calvete","year":"2017","journal-title":"Biochem. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e34947","DOI":"10.1371\/journal.pone.0034947","article-title":"Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7","volume":"7","author":"Chen","year":"2012","journal-title":"PloS one"},{"key":"B13","first-page":"385","article-title":"Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates","volume":"4","author":"Cheng","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.actatropica.2008.05.021","article-title":"Epidemiology of scorpionism: a global appraisal","volume":"107","author":"Chippaux","year":"2008","journal-title":"Acta Trop."},{"key":"B68","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1038\/mtna.2013.30","article-title":"Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatment","volume":"2","author":"Costa","year":"2013","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3791\/1610","article-title":"Microvolume protein concentration determination using the NanoDrop 2000c spectrophotometer","author":"Desjardins","year":"2009","journal-title":"J. Vis. Exp. JoVE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fphar.2020.00913","article-title":"Voltage-gated K+\/Na+ channels and scorpion venom toxins in cancer","volume":"11","author":"D\u00edaz-Garc\u00eda","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/toxins7020219","article-title":"AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities","volume":"7","author":"Du","year":"2015","journal-title":"Toxins"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29537","DOI":"10.1074\/jbc.271.47.29537","article-title":"Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood","volume":"271","author":"Ehret-Sabatier","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9998420","DOI":"10.1155\/2021\/9998420","article-title":"Scorpion-derived antiviral peptides with a special focus on medically important viruses: an update","volume":"2021","author":"El Hidan","year":"2021","journal-title":"BioMed Res. Int."},{"key":"B20","first-page":"11","article-title":"Piqures et Envenimations Scorpioniques (PES); Rapports general et specifiques","volume":"43","author":"El Oufir","year":"2019","journal-title":"Rev. Toxicol. Maroc. Cent. Anti Poison Du. Maroc. (CAPM) Rabat, Moroc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12985-015-0276-6","article-title":"Virocidal activity of Egyptian scorpion venoms against hepatitis C virus","volume":"12","author":"El-Bitar","year":"2015","journal-title":"Virology J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0014-5793(00)01239-4","article-title":"Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca2+ release channel\/ryanodine receptors","volume":"469","author":"Fajloun","year":"2000","journal-title":"FEBS Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/rcm.6628","article-title":"Comparison of the quantitative performance of a Q-exactive high\u2010resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater","volume":"27","author":"Fedorova","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"B24","doi-asserted-by":"publisher","first-page":"171139","DOI":"10.1016\/j.peptides.2023.171139","article-title":"Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity","volume":"173","author":"Ghazal","year":"2024","journal-title":"Peptides"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3389\/fmicb.2016.01844","article-title":"Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms","volume":"7","author":"Guilhelmelli","year":"2016","journal-title":"Front. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxicon.2014.06.006","article-title":"Antimicrobial peptides from scorpion venoms","volume":"88","author":"Harrison","year":"2014","journal-title":"Toxicon"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/life13051133","article-title":"Comparative proteomic analysis of the venoms from the Most dangerous scorpions in Morocco: androctonus mauritanicus and Buthus occitanus","volume":"13","author":"Hilal","year":"","journal-title":"Life"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/iect2023-14797","article-title":"Exploring the inter- and intra-specific variability of androctonus scorpion venoms","volume":"24","author":"Hilal","year":"","journal-title":"Biol. Life Sci. Forum"},{"key":"B29","doi-asserted-by":"publisher","first-page":"958797","DOI":"10.1155\/2013\/958797","article-title":"Scorpion peptides: potential use for new drug development","volume":"2013","author":"Hmed","year":"2013","journal-title":"J. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2013.11.013","article-title":"Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1","volume":"102","author":"Hong","year":"2014","journal-title":"Antivir. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.chembiol.2024.03.008","article-title":"SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs","volume":"31","author":"Iketani","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/toxins17080371","article-title":"Animal venom in modern medicine: a review of therapeutic applications","volume":"17","author":"Kim","year":"2025","journal-title":"Toxins"},{"key":"B69","first-page":"e53638","article-title":"Recombinant expression of margatoxin and agitoxin-2 in pichia pastoris: an efficient method for production of KV1.3 channel blockers","volume":"8","author":"King","year":"2013","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.13040\/IJPSR.0975-8232.3(12).4626-33","article-title":"Importance of RP-HPLC in analytical method development: a review","volume":"3","author":"Kumar","year":"2012","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"B35","article-title":"The structural universe of disulfide-rich venom peptides","author":"Lavergne","year":"2015"},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/157341206776819346","article-title":"Solid-phase extraction (SPE) techniques for sample preparation in clinical and pharmaceutical analysis: a brief overview","volume":"2","author":"Li","year":"2006","journal-title":"Curr. Pharm. Anal."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","article-title":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses","volume":"32","author":"Li","year":"2011","journal-title":"Peptides"},{"key":"B38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.peptides.2019.02.009","article-title":"Peptides with therapeutic potential in the venom of the scorpion Buthus martensii Karsch","volume":"115","author":"Li","year":"2019","journal-title":"Peptides"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3389\/fmicb.2018.01159","article-title":"Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant gram-positive bacteria","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1007\/s12033-024-01240-4","article-title":"Prospects of innovative therapeutics in combating the COVID-19 pandemic","volume":"67","author":"Mahendran","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"20210034","DOI":"10.1590\/1678-9199-JVATITD-2021-0034","article-title":"Toxinology in the proteomics era: a review on arachnid venom proteomics","volume":"28","author":"Marchi","year":"2022","journal-title":"J. Venom. Animals Toxins Incl. Trop. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40409-016-0089-0","article-title":"Antiviral activity of animal venom peptides and related compounds","volume":"23","author":"Mata","year":"2017","journal-title":"J. Venom. Animals Toxins Incl. Trop. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/ph17070891","article-title":"A dynamic and effective peptide-based strategy for promptly addressing emerging SARS-CoV-2 variants of concern","volume":"17","author":"Murdocca","year":"2024","journal-title":"Pharm. Basel, Switz."},{"key":"B44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/s0006-291x(02)02706-7","article-title":"Two new scorpion toxins that target voltage-gated Ca2+ and Na+ channels","volume":"299","author":"Olamendi-Portugal","year":"2002","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1039\/c6mb00516k","article-title":"Advances in venomics","volume":"12","author":"Oldrati","year":"2016","journal-title":"Mol. Biosyst."},{"key":"B46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon Official J. Int. Soc. Toxinology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JVI.03800-13","article-title":"A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4 and coreceptor-binding sites of gp120","volume":"88","author":"Quinlan","year":"2014","journal-title":"J. Virology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.toxicon.2013.07.012","article-title":"Scorpion venom components that affect ion-channels function","volume":"76","author":"Quintero-Hern\u00e1ndez","year":"2013","journal-title":"Toxicon"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1678-9199-19-5","article-title":"Comparison between two methods of scorpion venom milking in Morocco","volume":"19","author":"Oukkache","year":"2013","journal-title":"J. Venom. Anim. Toxins. Incl. Trop. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/187152811797200614","article-title":"From the stretcher to the pharmacy's shelf: drug leads from medically important Brazilian venomous arachnid species","volume":"10","author":"Rates","year":"2011","journal-title":"Inflamm. Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy) (Discontinued)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.peptides.2011.01.015","article-title":"Purification, synthesis and characterization of AaCtx, the first chlorotoxin-like peptide from Androctonus australis scorpion venom","volume":"32","author":"Rjeibi","year":"2011","journal-title":"Peptides"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.toxicon.2008.03.029","article-title":"Mass spectrometry analysis, amino acid sequence and biological activity of venom components from the Brazilian scorpion Opisthacanthus cayaporum","volume":"51","author":"Schwartz","year":"2008","journal-title":"Toxicon"},{"key":"B52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/BJ20061404","article-title":"Hemicalcin, a new toxin from the Iranian scorpion Hemiscorpius lepturus which is active on ryanodine-sensitive Ca2+ channels","volume":"404","author":"Shahbazzadeh","year":"2007","journal-title":"Biochem. J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470015902.a0000939.pub2","article-title":"Animal venoms: origin, diversity and evolution","author":"Suranse","year":"2018","journal-title":"eLS"},{"key":"B54","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2174\/0929866525666180614114307","article-title":"Scorpion venom peptides as a potential source for human drug candidates","volume":"25","author":"Uzair","year":"2018","journal-title":"Protein peptide Lett."},{"key":"B55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.crtox.2021.09.001","article-title":"Venom peptides - a comprehensive translational perspective in pain management","volume":"2","author":"V","year":"2021","journal-title":"Curr. Res. Toxicol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.toxicon.2020.02.021","article-title":"Transcriptomic and proteomic analyses of the venom and venom glands of Centruroides hirsutipalpus, a dangerous scorpion from Mexico","volume":"179","author":"Valdez-Vel\u00e1zquez","year":"2020","journal-title":"Toxicon"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9000","DOI":"10.1021\/ac7016234","article-title":"Comparison of MALDI to ESI on a triple quadrupole platform for pharmacokinetic analyses","volume":"79","author":"Volmer","year":"2007","journal-title":"Anal. Chem."},{"key":"B58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/15569548409097925","article-title":"Neurotoxic proteins in scorpion venom","volume":"3","author":"Watt","year":"1984","journal-title":"J. Toxicol. Toxin Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"106978","DOI":"10.1016\/j.phrs.2023.106978","article-title":"Scorpion venom peptides: molecular diversity, structural characteristics, and therapeutic use from channelopathies to viral infections and cancers","volume":"197","author":"Xia","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3390\/molecules29215080","article-title":"Antimicrobial potential of scorpion-venom-derived peptides","volume":"29","author":"Xia","year":"2024","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jprot.2014.04.032","article-title":"Proteomic analysis of the venom from the scorpion Mesobuthus martensii","volume":"106","author":"Xu","year":"2014","journal-title":"J. Proteomics"},{"key":"B62","article-title":"Optimization of the conditions for maximum recovery of venom from scorpions by electrical stimulation","volume":"48","author":"Yaqoob","year":"2016","journal-title":"Pak. J. Zoology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.yexmp.2011.04.008","article-title":"Scorpion (Androctonus crassi-cauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest","volume":"91","author":"Zargan","year":"2011","journal-title":"Experimental Mol. Pathology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/15216540500058899","article-title":"Scorpion venom peptides without disulfide bridges","volume":"57","author":"Zeng","year":"2005","journal-title":"IUBMB Life"},{"key":"B65","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/15569543.2019.1614064","article-title":"Nontoxic fraction of scorpion venom reduces bacterial growth and inflammatory response in a mouse model of infection","volume":"40","author":"Zerouti","year":"2019","journal-title":"Toxin Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"113244","DOI":"10.1016\/j.jim.2022.113244","article-title":"The spike-ACE2 binding assay: an in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies","volume":"503","author":"Zhang","year":"2022","journal-title":"J. Immunol. Methods"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1678606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:24:54Z","timestamp":1762151094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1678606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":68,"alternative-id":["10.3389\/fphar.2025.1678606"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1678606","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"1678606"}}